Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective cohort study of Jintiange capsules in knee osteoarthritis
ChiCTR2200065257Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Nov 2022
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of jintiange in knee osteoarthritis (OA) (2 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoints: Pain and Activities of daily living. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
jintiange
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2200065257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065257.